1. Home
  2. HSAI vs WVE Comparison

HSAI vs WVE Comparison

Compare HSAI & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSAI
  • WVE
  • Stock Information
  • Founded
  • HSAI 2014
  • WVE 2012
  • Country
  • HSAI China
  • WVE Singapore
  • Employees
  • HSAI N/A
  • WVE N/A
  • Industry
  • HSAI
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HSAI
  • WVE Health Care
  • Exchange
  • HSAI Nasdaq
  • WVE Nasdaq
  • Market Cap
  • HSAI 1.8B
  • WVE 1.7B
  • IPO Year
  • HSAI 2023
  • WVE 2015
  • Fundamental
  • Price
  • HSAI $15.30
  • WVE $6.73
  • Analyst Decision
  • HSAI
  • WVE Strong Buy
  • Analyst Count
  • HSAI 0
  • WVE 11
  • Target Price
  • HSAI N/A
  • WVE $22.00
  • AVG Volume (30 Days)
  • HSAI 5.9M
  • WVE 1.6M
  • Earning Date
  • HSAI 05-19-2025
  • WVE 05-08-2025
  • Dividend Yield
  • HSAI N/A
  • WVE N/A
  • EPS Growth
  • HSAI N/A
  • WVE N/A
  • EPS
  • HSAI N/A
  • WVE N/A
  • Revenue
  • HSAI $284,577,139.00
  • WVE $108,302,000.00
  • Revenue This Year
  • HSAI $68.02
  • WVE N/A
  • Revenue Next Year
  • HSAI $34.07
  • WVE N/A
  • P/E Ratio
  • HSAI N/A
  • WVE N/A
  • Revenue Growth
  • HSAI 10.66
  • WVE N/A
  • 52 Week Low
  • HSAI $3.52
  • WVE $4.25
  • 52 Week High
  • HSAI $24.18
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • HSAI 52.40
  • WVE 43.50
  • Support Level
  • HSAI $10.41
  • WVE $5.72
  • Resistance Level
  • HSAI $16.33
  • WVE $7.35
  • Average True Range (ATR)
  • HSAI 1.60
  • WVE 0.58
  • MACD
  • HSAI 0.37
  • WVE 0.23
  • Stochastic Oscillator
  • HSAI 82.60
  • WVE 70.05

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: